retatrutide clinical trial information Reta data & dosing — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 trials for metabolic health — targeting GLP-1, GIP New Weight Loss Drug Retatrutide:

If you have been researching retatrutide and are wondering whether it might be suitable for you, the most important first step is to have an open and informed conversation with your GP or a qualified prescriber

Ocular side effects There is a reported increased risk of diabetic retinopathy with GLP-1 agonists, specifically semaglutide (Ozempic, Wegovy) as demonstrated by the SUSTAIN-6 trial (HR 1.76

Compounded Tirzepatide Compounded tirzepatide contains tirzepatide as its active ingredient an FDA-recognized active ingredient used in several branded prescription weight management medications

Bydureon BCise (exenatide extended-release) injection, for subcutaneous use: prescribing information

toss until coated